Join Liz Beverly, PhD and Amber Healy, DO as they discuss the implications of Metabolic dysfunction–associated steatotic liver disease for patients with Type 2 Diabetes.
Join Sarah Adkins PharmD, RPh, BCACP and Umamahesh Yellamraju, MD, DO as they discuss the current trends and approaches around the topic of hypertension for individuals with type 2 diabetes.